AFMD: Affimed Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
NK-hujayralar aktivatsiyasi orqali immunoterapiyaning rivojlanishi kapital oqimlarini rag'batlantirmoqda, bu esa Affimed (AFMD) uchun hisoblangan PEG koeffitsiyentini tasdiqlaydi. Ushbu parametr 0.00 darajasida barqarorlashgan bo'lib, joriy bozor bahosini aks ettiradi. O'sish istiqbollari AI yordamida antitelar skriningini robotlashtirish va laboratoriya materiallarini utilizatsiya qilish bo'yicha Yevropa biosafety standartlariga qat'iy rioya qilishga asoslangan.
Affimed (AFMD) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Affimed|AFMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi affimed.com|AFMD - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Affimed Therapeutics|AFMD - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Affimed|Kritik likvidlik koeffitsiyenti affimed.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AFMD - Sof foyda|Forvard foyda Affimed|AFMD - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati affimed.com|AFMD - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Affimed Therapeutics|AFMD - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Affimed|AFMD - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi affimed.com|AFMD - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Affimed
Kompaniyaning umumiy tahlili:AFMD - Affimed NV
Affimed (AFMD) o'zining maxsus bispesifik antitanalar texnologiyasi orqali yuqori qo'shilgan qiymat yaratadi, bu esa aksiyaning baholanishida PEG koeffitsiyenti orqali aks etadi. Ushbu ko'rsatkich narx-foyda koeffitsiyentini foyda o'sish sur'ati bilan solishtiradi: birdan past qiymat aktivning biznes dinamikasiga nisbatan past baholanganligini anglatadi, bu esa investorlarga fundamental xavfsiz boshpana zaxirasini saqlagan holda, aksiyalar narxining keskin ko'tarilishi potentsialini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|ABCL: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TRML (tourmalinebio.com)|PGEN (Precigen) - PEG multiplikatori|Pharming Group NV - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori NKTR|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Upstream Pharma|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|IMNM - Narx-foyda va o‘sish multiplikatori|Gossamer Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda KalVista Pharma|SEPN: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti PVLA|SVRA (Savara Inc.) - PEG multiplikatori|PEG multiplikatori rigel.com|PEG multiplikatori ANAB|ATXS: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT - Narx-foyda va o‘sish multiplikatori|Aerovate - PEG multiplikatori|ACRS (aclaristx.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TLSA (Tiziana Life Sciences Ltd.)|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|VTYX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori THTX|PEG multiplikatori avalotx.com (AVTX)|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AGEN|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|zurabio.com (ZURA) - Narx-foyda va o‘sish multiplikatori|ATYR: PEG multiplikatori|Adagene Inc. (ADAG) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori IMA|STTK: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori EQ|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati connectbiopharm.com|Narxning foydaga va o‘sish sur’atiga nisbati Immunic IMUX|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|X4 Pharmaceuticals Inc. (XFOR) - Narx-foyda va o‘sish multiplikatori|ACET (adicetbio.com) - Narx-foyda va o‘sish multiplikatori|Celularity (CELU) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BRNS (barinthusbio.com)|PEG multiplikatori KZR|SABS - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori AKTX (Akari Therapeutics plc)|PEG multiplikatori Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati GOVX|EDSA: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati IBIO (iBio Inc)|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|XTL Bio (XTLB) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics (BOLT)|Narx-foyda va o‘sish multiplikatori hcwbiologics.com HCWB|PEG multiplikatori APVO (Aptevo Therapeutics Inc.)|aimimmuno.com (AIM) - O‘sish sur’atiga tuzatilgan narx-foyda|Aditxt Corp - PEG multiplikatori|GRI (GRI Bio Corporation) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|XRTX: PEG multiplikatori|reshapelifesciences.com (HIND) - PEG multiplikatori|REVB (Revelation Biosciences, Inc.) - PEG multiplikatori|Indaptus Therapeutics Inc - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Scinai (SCNI)|Narx-foyda va o‘sish multiplikatori calcimedica.com CALI|PEG multiplikatori ALLK (Allakos)|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ITOS|OCEA: PEG multiplikatori|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|THRD (Third Harmonic Bio) - PEG multiplikatori
